In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Emerox 1144 Drug Master File in Korea (Emerox 1144 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Emerox 1144. The MFDS reviews the Emerox 1144 KDMF as part of the drug registration process and uses the information provided in the Emerox 1144 KDMF to evaluate the safety and efficacy of the drug.
After submitting a Emerox 1144 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Emerox 1144 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Emerox 1144 suppliers with KDMF on PharmaCompass.